评价注射用rhEGF治疗晚期DFU的有效性和安全性的随机双盲多中心安慰剂平行对照的III期临床研究
[Translation] A randomized, double-blind, multicenter, placebo-controlled phase III clinical study to evaluate the efficacy and safety of rhEGF for injection in the treatment of advanced DFU
评估局部注射用重组人表皮生长因子用于晚期糖尿病足溃疡(Wagner分级3、4级)和有重度截肢风险的患者病灶内和病灶周围给药的疗效和安全性。
[Translation] To evaluate the efficacy and safety of local injection of recombinant human epidermal growth factor for intralesional and perilesional administration in patients with advanced diabetic foot ulcers (Wagner grade 3 and 4) and those at high risk for amputation.
100 Clinical Results associated with Huake Pharmaceutical Intellectual Property Consulting Center
0 Patents (Medical) associated with Huake Pharmaceutical Intellectual Property Consulting Center
100 Deals associated with Huake Pharmaceutical Intellectual Property Consulting Center
100 Translational Medicine associated with Huake Pharmaceutical Intellectual Property Consulting Center